Parkinson’s disease: oxidative stress and therapeutic approaches

By Surendran Sankar   Rajasankar Srinivasagam  

Neurological Sciences, Vol. 31, Iss. 5, 2010-10 ,pp. : 531-540

Springer Publishing Company

Access to resources Recommend Favorite

Neuroprotective Effect of CNB-001, a Novel Pyrazole Derivative of Curcumin on Biochemical and Apoptotic Markers Against Rotenone-Induced SK-N-SH Cellular Model of Parkinson’s Disease

By Jayaraj Richard   Tamilselvam Kuppusamy   Manivasagam Thamilarasan   Elangovan Namasivayam  

Journal of Molecular Neuroscience, Vol. 51, Iss. 3, 2013-11 ,pp. : 863-870

Humana Press, Inc

Access to resources Recommend Favorite

The rotenone model of Parkinson's disease

By Perier C.   Bove J.   Vila M.   Przedborski S.  

Trends in Neurosciences, Vol. 26, Iss. 7, 2003-07 ,pp. : 345-346

Elsevier

Access to resources Recommend Favorite

Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: Implications for the pathogenesis of Parkinson’s disease

By Elkon Hanoch   Melamed Eldad   Offen Daniel  

Journal of Molecular Neuroscience, Vol. 24, Iss. 3, 2004-10 ,pp. : 387-400

Humana Press, Inc

Access to resources Recommend Favorite

Effects of exercise induced oxidative stress on glutathione levels in Parkinson’s disease on and off medication

By Elokda Ahmed   DiFrancisco-Donoghue Joanne   Lamberg Eric   Werner William  

Journal of Neurology, Vol. 257, Iss. 10, 2010-10 ,pp. : 1648-1653

Springer Publishing Company

Access to resources Recommend Favorite